Synapse - Works

Results (13087)

Results of SWOG 1318: A phase 2 trial of blinatumomab followed by POMP (prednisone, vincristine, methotrexate, 6-mercaptopurine) maintenance in elderly patients with newly diagnosed Philadelphia chromosome negative B-cell acute lymphoblastic leukemia

Meeting Abstract

Advani, A. S.; Moseley, A.; O'Dwyer, K. M.; Wood, B.; Fang, M.; Wieduwilt, M. J.; Aldoss, I.; Park, J. H.; Klisovic, R.; Baer, M. R.; more...
Blood (2018)

Fulltext@MSK | Save

Phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory classic Hodgkin lymphoma: Part 3 (concurrent dosing) results and updated progression-free survival results from parts 1 and 2 (staggered dosing)

Meeting Abstract

Advani, R. H.; Moskowitz, A. J.; Bartlett, N. L.; Vose, J. M.; Ramchandren, R.; Feldman, T. A.; LaCasce, A. S.; Christian, B. A.; Ansell, S. M.; Moskowitz, C. H.; more...
Blood (2018)

Fulltext@MSK | Save

Targeted conditioning of Iomab-B ((131)I-anti-CD45) prior to allogeneic hematopoietic cell transplantation versus conventional care in relapsed or refractory acute myeloid leukemia (AML): Preliminary feasibility and safety results from the prospective, randomized phase 3 SIERRA trial

Meeting Abstract

Agura, E.; Gyurkocza, B.; Nath, R.; Litzow, M. R.; Tomlinson, B. K.; Abhyankar, S.; Seropian, S.; Stiff, P. J.; Choe, H. K.; Kebriaei, P.; more...
Blood (2018)

Fulltext@MSK | Save

Differentiating lung involvement in adult T-cell leukemia lymphoma (ATLL) versus HTLV infection: Results from a large single-center cohort with implications for staging and response criteria

Meeting Abstract

Acuna-Villaorduna, A.; Gonzalez-Lugo, J. D.; Ye, B. H.; Shah, U. A.; Kaur, G.; Shah, N.; Mantzaris, I.; Shastri, A.; Braunschweig, I.; Kornblum, N.; more...
Blood (2018)

Fulltext@MSK | Save

A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis

Meeting Abstract

Yu, K.; Mantha, S.; Tjan, C.; Kaufmann, E.; Brenner, R. B.; Lowery, M.; Ku, G.; Raj, N.; Shcherba, M.; Goldberg, Z.; more...
Annals of Oncology (2018)

Fulltext@MSK | Save

A phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC)

Meeting Abstract

O'Cearbhaill, R. E.; Wolfer, A.; Disilvestro, P.; O'Malley, D. M.; Sabbatini, P.; Shohara, L.; Schwarzenberger, P. O.; Ricciardi, T.; Macri, M.; Ryan, A.; more...
Annals of Oncology (2018)

Fulltext@MSK | Save

PD-L1 expression and T-cell inflamed gene expression profile (GEP) in Korean and US patients (pts) with advanced gastric cancer (GC)

Meeting Abstract

Rha, S. Y.; Ku, G. Y.; Kim, H. S.; Chung, H. C.; Amlashi, F. G.; Maru, D. M.; Fein, C.; Tang, L.; Savage, M. J.; Zhou, W.; more...
Annals of Oncology (2018)

Fulltext@MSK | Save

REVEAL: A phase I/II, open-label, multicenter, dose escalation and dose expansion study of NKTR-262 [TLR 7/8 agonist] plus NKTR-214 [CD122-biased agonist] with or without nivolumab (nivo) in patients (pts) with locally advanced or metastatic solid tumor malignancies

Meeting Abstract

Diab, A.; Marcondes, M.; Tagliaferri, M. A.; Hoch, U.; Zhang, J.; Rubas, W.; Kivimae, S.; Zalevsky, J.; Conley, A. P.; Borazanci, E.; more...
Annals of Oncology (2018)

Fulltext@MSK | Save

Responder analysis based on patient-reported outcomes (PROs) and clinical endpoints (CEPs) in patients (pts) with metastatic Merkel cell carcinoma (mMCC) treated with avelumab

Meeting Abstract

D'Angelo, S. P.; Fofana, F.; Schlichting, M.; Henry-Szatkowski, M.; Hennessy, M.; Bharmal, M.
Annals of Oncology (2018)

Fulltext@MSK | Save

Targeting the CALR interactome in myeloproliferative neoplasms

Journal Article

Pronier, E.; Cifani, P.; Merlinsky, T. R.; Berman, K. B.; Somasundara, A. V. H.; Rampal, R. K.; LaCava, J.; Wei, K. E.; Pastore, F.; Maag, J. L. V.; more...
JCI Insight (2018)

Fulltext@MSK | Save